FindTrial
Sign In

A clinical study to assess the effectiveness of Panchatikta Niruha Basti in managing Kitibha Kushta in comparison to Psoriasis.

A clinical study to evaluate the efficacy of Panchatikta Niruha Basti in the management of Kitibha Kushta vis a vis psoriasis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071684
Enrollment
30
Registered
2024-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Dr Farheen Domani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects fulfilling diagnostic criteria,Subjects between age group of 18– 60 years, irrespective of gender, Subject fit for basti karma,Subject with Both freshly diagnosed and treated cases

Exclusion criteria

Exclusion criteria: Subject having symptoms like pustular psoriasis, generalized edema,cellulitis, and other dermatological conditions except psoriasis,Subjects with stage 2 Hypertension(160/100),Subject with diabetes mellitus,Pregnant and lactating women,Subjects with other systemic illnesses which interfere with the intervention.

Design outcomes

Primary

MeasureTime frame
Reduction of symptoms of kitibha kushta (psoriasis)like Shyavam/Aruna – brownish-black discolouration/erythematous lesion khinakara sparsha : rough surface of the lesion Khara sparsha-dry and scaly lesion Parusha: hard lesion Kandu: itching sensation Drudham-sharply circumscribed lesion Timepoint: 6 weeks—

Secondary

MeasureTime frame
rate of reoccurrence of kitbha kushta(psoriasis)Timepoint: 2 months—

Countries

India

Contacts

Public ContactDr FarheenADomani

Government Ayurvedic Medical College Mysuru

kulkarnidrvarsha@gmail.com7676848402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026